Forskolin is notable for its capacity to elevate cAMP levels by stimulating adenylyl cyclase, which in turn can enhance the activity of proteins like SPNS3 via cAMP-dependent pathways. Another compound, IBMX, operates by inhibiting phosphodiesterases, which leads to an accumulation of cAMP within the cell, again supporting the activity of SPNS3. Dibutyryl cAMP, a synthetic analog of cAMP, can permeate cell membranes and mimic the action of endogenous cAMP, thus activating the same pathways and potentially upregulating SPNS3. Additionally, ionophores such as A23187 and Ionomycin effectively increase intracellular calcium concentrations, a signal that can activate numerous calcium-dependent proteins and pathways interconnected with SPNS3 function.
Protein kinase C, a pivotal signaling molecule in cells, is activated by compounds like PMA. This activation can trigger a signaling cascade that may intersect with the pathways regulating SPNS3. Genistein, a tyrosine kinase inhibitor, can also modulate signaling networks, ultimately influencing the activity of SPNS3. LY294002 disrupts PI3K/AKT signaling, while U0126 and PD98059 target the MAPK/ERK pathway by inhibiting MEK enzymes. These inhibitors can create a shift in cellular signaling dynamics, potentially resulting in the modulation of SPNS3 activity. SB203580's inhibition of p38 MAPK can similarly influence the signaling environment to affect proteins like SPNS3. Sodium orthovanadate acts as an inhibitor of protein tyrosine phosphatases, leading to an altered phosphorylation state of cellular proteins which may include regulatory proteins that control SPNS3 activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, increases cAMP by preventing its breakdown, indirectly enhancing SPNS3. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Cell-permeable cAMP analog that can activate cAMP-dependent pathways, thereby indirectly promoting SPNS3 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Ionophore that increases intracellular calcium levels, potentially activating calcium-dependent pathways involving SPNS3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which can modulate signaling pathways that may upregulate SPNS3 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, similarly to A23187, potentially enhancing SPNS3 activity via calcium signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor that can modulate signaling pathways, potentially resulting in upregulation of SPNS3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can affect downstream signaling, which may include pathways regulating SPNS3 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that can alter the MAPK/ERK pathway, possibly leading to changes in SPNS3 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that may influence pathways affecting SPNS3 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor, similar to U0126, that can modulate the MAPK/ERK pathway, affecting SPNS3 activity. | ||||||